The Latin America, Middle East and Africa Coronary Heart Disease Diagnostic Imaging Devices Market would witness market growth of 9.9% CAGR during the forecast period (2022-2028).
IVUS has evolved into a valuable technique for assessing and characterizing coronary arteries and atherosclerotic plaques. IVUS is an invasive method that employs a tiny ultrasound transducer attached to a catheter similar to those used in coronary angioplasty to produce images. The catheter is pushed through the coronary artery on a wire until it reaches a point distal to the segment to be investigated. As the catheter is gently brought out, a series of tomographic pictures of the coronary artery are taken. As the catheter is gently brought out, a series of tomographic pictures of the coronary artery are taken. Each IVUS image shows the sections of the coronary artery (intima, medium, and adventitia) as well as the lumen in a 360° cross-section. Online 3-dimensional reconstructions of a plaque's length, volume, and reference landmarks are now possible with modern technologies. Therefore, with the rapidly going technological advancements all over the world, the demand for coronary heart imaging diagnostic imaging solutions is increasing. This factor is estimated to propel the growth of the market in the coming years.
Smoking, hypertension, hyperlipidemia, diabetes, obesity, hyperlipidemia, physical inactivity, and poor dietary habits, all of which are modifiable atherothrombotic CVD risk factors in HIC populations, are now palpably emerging in SSA. However, the full cost of these risk factors and their consequences in SSA is unknown since most countries lack data or have insufficient data collection methods that are not reliable enough to allow for a proportionate health-system response.
Smoking rates are 10% in Sub-Saharan Africa versus 30% in High-Income Countries. Hypertension prevalence is 30% in Sub-Saharan Africa (40% in urban and 20% in rural populations) versus 20% in Higher Income Countries. Diabetes prevalence is 7.1% in men and women in SSA versus 6–8% in men as well as 3–6% in women in High-Income Countries. Dyslipidemia prevalence in adults is 25% in SSA versus 40–60 % in HIC. In the account of these numbers, the region is estimated to witness a very high prevalence of cardiovascular disorders in the coming years. This factor would increase the demand for effective imaging devices across the region. Therefore, the regional market is anticipated to flourish owing to these reasons.
The Brazil market dominated the LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $35.3 Million by 2028. The Argentina market is experiencing a CAGR of 10.5% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 9.7% during (2022 - 2028).
Based on Modality, the market is segmented into Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Coronary Heart Disease Diagnostic Imaging Devices Market is Predict to reach $2.1 Billion by 2028, at a CAGR of 6.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon, Inc. (Canon Medical Systems Corporation), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., and Analogic Corporation (Altaris Capital Partners).
Scope of the Study
Market Segments Covered in the Report:
- Nuclear Medicine
- Computed Tomography
- Ultrasound
- X rays
- Magnetic Resonance Imaging
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Canon, Inc. (Canon Medical Systems Corporation)
- Mindray Medical International Limited
- Chison Medical Technologies Co., Ltd.
- Analogic Corporation (Altaris Capital Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market, by Modality
1.4.2 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Mar – 2022, Feb) Leading Players
Chapter 4. LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
4.1 LAMEA Nuclear Medicine Market by Country
4.2 LAMEA Computed Tomography Market by Country
4.3 LAMEA Ultrasound Market by Country
4.4 LAMEA X rays Market by Country
4.5 LAMEA Magnetic Resonance Imaging Market by Country
Chapter 5. LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Country
5.1 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market
5.1.1 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.2 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market
5.2.1 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.3 UAE Coronary Heart Disease Diagnostic Imaging Devices Market
5.3.1 UAE Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.4 Saudi Arabia Coronary Heart Disease Diagnostic Imaging Devices Market
5.4.1 Saudi Arabia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.5 South Africa Coronary Heart Disease Diagnostic Imaging Devices Market
5.5.1 South Africa Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.6 Nigeria Coronary Heart Disease Diagnostic Imaging Devices Market
5.6.1 Nigeria Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.7 Rest of LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market
5.7.1 Rest of LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
Chapter 6. Company Profiles
6.1 General Electric (GE) Co. (GE Healthcare)
6.1.1 Company Overview
6.1.1 Financial Analysis
6.1.2 Segmental and Regional Analysis
6.1.3 Research & Development Expense
6.1.4 Recent Strategies and Developments:
6.1.4.1 Partnerships, Collaborations and Agreements:
6.1.4.2 Approvals and Trials:
6.1.5 SWOT Analysis
6.2 Koninklijke Philips N.V.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Partnerships, Collaborations and Agreements:
6.2.5.2 Acquisitions and Mergers:
6.3 Siemens Healthineers AG (Siemens AG)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent Strategies and Developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Fujifilm Holdings Corporation
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent Strategies and Developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Canon, Inc. (Canon Medical Systems Corporation)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Product Launches and Product Expansions:
6.6 Mindray Medical International Limited
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Product Launches and Product Expansions:
6.7 Chison Medical Technologies Co., Ltd.
6.7.1 Company Overview
6.8 Analogic Corporation (Altaris Capital Partners)
6.8.1 Company Overview
TABLE 1 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 4 Product Launches And Product Expansions– Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 5 Acquisition and Mergers– Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 6 Approvals and Trials - Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 7 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 8 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 9 LAMEA Nuclear Medicine Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Nuclear Medicine Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Computed Tomography Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Computed Tomography Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Ultrasound Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Ultrasound Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA X rays Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA X rays Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Magnetic Resonance Imaging Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Magnetic Resonance Imaging Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Country, 2022 - 2028, USD Million
TABLE 21 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 22 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 23 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 24 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 25 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 26 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 27 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 28 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 29 UAE Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 30 UAE Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 31 UAE Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 32 UAE Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 33 Saudi Arabia Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 34 Saudi Arabia Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 35 Saudi Arabia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 36 Saudi Arabia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 37 South Africa Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 38 South Africa Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 39 South Africa Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 40 South Africa Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 41 Nigeria Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 42 Nigeria Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 43 Nigeria Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 44 Nigeria Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 45 Rest of LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 46 Rest of LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 47 Rest of LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 48 Rest of LAMEA Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 49 Key Information – General Electric (GE) Co.
TABLE 50 Key Information – Koninklijke Philips N.V.
TABLE 51 Key Information – Siemens Healthineers AG
TABLE 52 Key Information – Fujifilm Holdings Corporation
TABLE 53 Key Information – Canon, Inc.
TABLE 54 Key Information – Mindray Medical International Limited
TABLE 55 Key Information – CHISON MEDICAL TECHNOLOGIES CO., LTD.
TABLE 56 Key information – Analogic Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Mar – 2022, Feb) Leading Players
FIG 5 Swot analysis: General electric (GE) Co.
FIG 6 Recent strategies and developments: Koninklijke Philips N.V.
FIG 7 Recent strategies and developments: Canon, Inc.